aspsirna0430 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna0430
siRNA Name: P3
Gene:Presenilin1 (PSEN1)
Disease:Alzheimers disease
Wild allele/target (5'->3'): UUCUGGUUGGUAAAGCCUC
Mutant allele/target (5'->3'):UUGUGGUUGGUAAAGCCUC
Target Mutation: c.811C>G, p.Leu271Val
Wild siRNA (As strand):AAGACCAACCAUUUCGGAG
ASP-siRNA (As strand):AACACCAACCAUUUCGGAG
Mismatch position in siRNA: C17G
Mutant allele (5'->3'): UUGUGGUUGGUAAAGCCUC
ASP-siRNA (As strand):AACACCAACCAUUUCGGAG
ASP-siRNA efficacy for mutant allele:54
Wild allele (5'->3'): UUCUGGUUGGUAAAGCCUC
ASP-siRNA (As strand):AACACCAACCAUUUCGGAG
ASP-siRNA efficacy for wild allele:28
Percentage discrimination for ASP-siRNA:26
Wild allele (5'->3'): UUCUGGUUGGUAAAGCCUC
Wild siRNA (As strand):AAGACCAACCAUUUCGGAG
Wild sirna efficacy for wild allele:NA
Wild allele (5'->3'): UUCUGGUUGGUAAAGCCUC
ASP-siRNA (As strand):AACACCAACCAUUUCGGAG
Wild sirna efficacy for mutant allele:NA
Percentage discrimination for wild siRNA:NA
Concentration:1.5microL
Orientation:Sense
Mismatch in:siRNA
UniProt ID: P49768
Target sequence: UUCAUUUUCUACAGUGUUCUGGUUGGUAAAGCCUCAG
Genbank Accesion: NM_000021.3
Cell-line: HeLa
Experimental technique used: Dual luciferase reporter assay
Transfection method: Lipofectamine 2000
siRNA expression method: Chemically synthesized (Phosphoramidite method)
Post-transfection duration: 48 hours
OMID ID: 104300
KEGG disease ID:H00056
Reference:21559198

.
.
.
.
.
.
.
.
.
.
.

.

.

.